AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Panbela Therapeutics, Inc.

$0 -$0.01 (-99.24%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.02
Year Range
$0$2.5
Market Cap
485
AVG Volume
959
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
Other OTCUS
Revenue (USD)
-2M-1.5M-1M-500K022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Revenue (USD) by quarter
PeriodRevenue (USD)
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
23 Q20
23 Q10
22 Q4-1.64M
22 Q30
22 Q20
Net Income (USD)
-30M-20M-10M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Net Income (USD) by quarter
PeriodNet Income (USD)
24 Q3-7.17M
24 Q2-7.14M
24 Q1-7.12M
23 Q4-6.47M
23 Q3-7.83M
23 Q2-5.83M
23 Q1-5.11M
22 Q4-4.73M
22 Q3-4.4M
22 Q2-22.13M
Operating Income (USD)
-30M-20M-10M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Operating Income (USD) by quarter
PeriodOperating Income (USD)
24 Q3-14.33M
24 Q2-8.1M
24 Q1-6.73M
23 Q4-7.04M
23 Q3-15.69M
23 Q2-5.88M
23 Q1-4.86M
22 Q4-5.12M
22 Q3-3.62M
22 Q2-21.29M
EBITDA (USD)
-60M-40M-20M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA EBITDA (USD) by quarter
PeriodEBITDA (USD)
24 Q3-6.73M
24 Q2-6.06M
24 Q1-7.2M
23 Q4-6.42M
23 Q3-7.78M
23 Q2-5.91M
23 Q1-5.01M
22 Q4-5.18M
22 Q3-3.62M
22 Q2-42.57M
Cash Flows (USD)
-10M-7.5M-5M-2.5M022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Cash Flows (USD) by quarter
PeriodCash Flows (USD)
24 Q3-2.12M
24 Q2-981K
24 Q1-9.39M
23 Q4-3.08M
23 Q3-6.68M
23 Q2-5.74M
23 Q1-9.75M
22 Q4-5M
22 Q3-1.59M
22 Q2-4.2M
EPS (USD)
-40000-30000-20000-10000022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA EPS (USD) by quarter
PeriodEPS (USD)
24 Q3-1.48
24 Q2-1.47
24 Q1-2.28
23 Q4-0.03
23 Q3-53.74
23 Q2-159.09
23 Q1-392.76
22 Q4-3409.76
22 Q3-5083.91
22 Q2-36243.78
Expenses (USD)
-10M010M20M30MR&DSG&ACapex22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Expenses (USD) by quarter
PeriodExpenses (USD)
24 Q37.17M
24 Q28.1M
24 Q16.73M
23 Q47.04M
23 Q37.85M
23 Q25.88M
23 Q14.86M
22 Q45.12M
22 Q33.62M
22 Q221.29M
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
24 Q3142K
24 Q259K
24 Q1262K
23 Q42.58M
23 Q3907K
23 Q27.21M
23 Q15.24M
22 Q41.28M
22 Q3941K
22 Q22.53M
Debt ratios
-0.3-0.2-0.1-00.10.222 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Debt ratios by quarter
PeriodDebt ratios
24 Q3-0.24
24 Q2-0.15
24 Q1-0.14
23 Q4-0.1
23 Q3-0.18
23 Q20.1
23 Q10
22 Q4-0.1
22 Q3-0.11
22 Q2-0.08
Margins
0%100%200%300%15 Q115 Q215 Q416 Q417 Q418 Q419 Q420 Q421 Q422 Q4
PBLA Margins by quarter
PeriodMargins
22 Q4200%
21 Q4200%
20 Q4100%
19 Q4200%
18 Q4200%
17 Q4200%
16 Q4200%
15 Q4232.68%
15 Q251.18%
15 Q149.21%
Return on Capital
-400%-200%0%200%400%600%22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Return on Capital by quarter
PeriodReturn on Capital
24 Q339.48%
24 Q267.55%
24 Q1223.48%
23 Q4137.45%
23 Q3315.38%
23 Q2-121.47%
23 Q1-201.7%
22 Q458.8%
22 Q353.17%
22 Q2457.42%
Shares Outstanding
02M4M6M22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Shares Outstanding by quarter
PeriodShares Outstanding
24 Q34.85M
24 Q24.85M
24 Q13.13M
23 Q43.13M
23 Q3145.73K
23 Q236.66K
23 Q113.02K
22 Q41.39K
22 Q3865
22 Q2610
Book Value Per Share (USD)
-10000-7500-5000-25000250022 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
24 Q3-3.74
24 Q2-2.18
24 Q1-1.02
23 Q4-1.51
23 Q3-17.04
23 Q2130.97
23 Q1194.73
22 Q4-5798.99
22 Q3-9571.1
22 Q2-7931.15
Total Assets (USD)
05M10M15M20M22 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q3
PBLA Total Assets (USD) by quarter
PeriodTotal Assets (USD)
24 Q35.17M
24 Q29.41M
24 Q110.53M
23 Q411.8M
23 Q310.63M
23 Q219.55M
23 Q116.48M
22 Q44.98M
22 Q34.87M
22 Q26.56M
Employee Count
05001K1.5K2K2012201520162017201820192020202120222023
PBLA Employee Count by quarter
PeriodEmployee Count
20238
20227
20216
20206
20195
20185
20176
20169
20159
20122K
Free Cash Flow Yield
-400000000%-300000000%-200000000%-100000000%0%med -6415.43%Jan 25May 25Sep 25Jan 26May 26Sep 26
PBLA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-3207712.94%
Sep 26-3207712.94%
Aug 26-3207712.94%
Aug 26-3207712.85%
Aug 26-320771284.7%
Aug 26-28898.31%
Jul 26-28898.31%
Jul 26-28898.31%
Jul 26-28898.31%
Jul 26-28898.31%
Jul 26-28898.31%
Jun 26-64154.26%
Jun 26-28898.31%
Jun 26-28898.31%
Jun 26-28898.31%
May 26-29161.03%
May 26-320771.28%
May 26-320771.28%
May 26-320771.28%
May 26-28898.31%
Apr 26-28898.31%
Apr 26-1603856.46%
Apr 26-1603856.42%
Apr 26-1603856.46%
Mar 26-1603856.46%
Mar 26-1603856.46%
Mar 26-1603856.46%
Mar 26-24580.18%
Feb 26-6415.43%
Feb 26-64154.26%
Feb 26-28898.31%
Feb 26-28898.31%
Jan 26-49349.43%
Jan 26-320771.28%
Jan 26-320771.28%
Jan 26-641542.57%
Jan 26-24486.36%
Dec 25-291610.26%
Dec 25-1069237.62%
Dec 25-16038.56%
Dec 25-20628.38%
Nov 25-28898.31%
Nov 25-28898.31%
Nov 25-28898.31%
Nov 25-16038.56%
Oct 25-16038.56%
Oct 25-28898.31%
Oct 25-15958.77%
Oct 25-28898.31%
Oct 25-28898.31%
Sep 25-6415.43%
Sep 25-6402.62%
Sep 25-6415.43%
Sep 25-2138.48%
Aug 25-2031.48%
Aug 25-2031.48%
Aug 25-2031.48%
Aug 25-2031.48%
Aug 25-1886.89%
Jul 25-2031.48%
Jul 25-2004.82%
Jul 25-1526.76%
Jul 25-2004.82%
Jun 25-1527.48%
Jun 25-1366.73%
Jun 25-1069.24%
Jun 25-1129.08%
May 25-1243.3%
May 25-1352.89%
May 25-1283.09%
May 25-1030.76%
May 25-1336.55%
Apr 25-999.29%
Apr 25-1145.61%
Apr 25-1002.41%
Apr 25-936.56%
Mar 25-944.44%
Mar 25-963.28%
Mar 25-864.61%
Mar 25-916.49%
Feb 25-822.49%
Feb 25-767.21%
Feb 25-943.44%
Feb 25-909.99%
Jan 25-916.49%
Jan 25-763.56%
Jan 25-864.61%
Jan 25-866.95%
Jan 25-784.28%
Dec 24-972.03%
Dec 24-986.99%
Dec 24-997.89%
Dec 24-1002.41%
Nov 24-993.1%
Nov 24-918.48%
Nov 24-986.23%
Nov 24-1271.89%
Nov 24-1120.64%
Oct 24-1184.67%
Oct 24-1299.6%
Price to Sales
-20-15-10-50med -1.05Jul 22Oct 22Jan 23May 23Aug 23Dec 23Mar 24
PBLA Price to Sales by quarter
PeriodPrice to Sales
Mar 24-0.06
Mar 24-0.05
Mar 24-0.05
Mar 24-0.11
Feb 24-0.1
Feb 24-0.11
Feb 24-0.11
Feb 24-0.1
Jan 24-0.38
Jan 24-0.61
Jan 24-1.12
Jan 24-1.19
Dec 23-1.63
Dec 23-1.59
Dec 23-0.81
Dec 23-0.85
Dec 23-1.06
Nov 23-0.93
Nov 23-1.04
Nov 23-1.06
Nov 23-0.32
Oct 23-0.33
Oct 23-0.36
Oct 23-0.46
Oct 23-0.51
Sep 23-0.59
Sep 23-0.56
Sep 23-0.59
Sep 23-0.62
Sep 23-0.65
Aug 23-0.59
Aug 23-0.68
Aug 23-0.73
Aug 23-0.27
Jul 23-0.32
Jul 23-0.34
Jul 23-0.33
Jul 23-0.34
Jun 23-0.37
Jun 23-0.36
Jun 23-0.41
Jun 23-1.1
Jun 23-1.05
May 23-1.6
May 23-1.81
May 23-1.81
May 23-2.08
Apr 23-0.28
Apr 23-0.24
Apr 23-0.29
Apr 23-0.18
Mar 23-0.23
Mar 23-0.26
Mar 23-0.26
Mar 23-0.29
Mar 23-0.39
Feb 23-0.53
Feb 23-0.57
Feb 23-0.56
Feb 23-0.65
Jan 23-0.61
Jan 23-1.24
Jan 23-1.42
Jan 23-1.33
Dec 22-1.25
Dec 22-1.4
Dec 22-1.57
Dec 22-1.69
Dec 22-1.83
Nov 22-2.27
Nov 22-2.27
Nov 22-1.97
Nov 22-1.54
Oct 22-1.66
Oct 22-2.24
Oct 22-2.69
Oct 22-2.88
Sep 22-3.26
Sep 22-3.26
Sep 22-7
Sep 22-6.27
Sep 22-8.56
Aug 22-8.32
Aug 22-10.25
Aug 22-14.26
Aug 22-15.49
Jul 22-13.72
Jul 22-15.17
Jul 22-12.28
Jul 22-13.18
Jul 22-8.19
Jun 22-6.78
Jun 22-13.95
Jun 22-15.6
Jun 22-15.5
May 22-17.27
May 22-16.04
May 22-17.72
May 22-18.28
Apr 22-19.54
Price/Operating Cashflow
253.75254254.25254.5254.75255med 253.9May 15May 15Jun 15Jun 15Jul 15Jul 15Aug 15
PBLA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 15253.9
Jul 15253.9
Jul 15253.9
Jul 15253.9
Jul 15253.9
Jul 15253.9
Jun 15253.9
Jun 15253.9
Jun 15253.9
Jun 15253.9
May 15253.9
May 15253.9
May 15253.9
Price to Book
050100150med 2.29May 21Sep 21Dec 21Apr 22Jul 22Jul 23Nov 23
PBLA Price to Book by quarter
PeriodPrice to Book
Nov 230.11
Oct 230.11
Oct 230.12
Oct 230.16
Oct 230.18
Sep 230.2
Sep 230.19
Sep 230.2
Sep 230.21
Sep 230.22
Aug 230.2
Aug 230.23
Aug 230.25
Aug 230.18
Jul 230.2
Jul 230.22
Jul 230.21
Jul 230.22
Jun 230.24
Jun 230.23
Jun 230.27
Jun 230.71
Jun 230.68
May 231.04
May 231.17
May 231.17
May 231.34
Aug 222.63
Aug 222.86
Jul 222.53
Jul 222.8
Jul 222.27
Jul 222.43
Jul 221.51
Jun 221.25
Jun 222.58
Jun 222.88
Jun 222.86
May 223.19
May 222.96
May 223.27
May 222.17
Apr 222.33
Apr 222.3
Apr 222.6
Apr 222.6
Apr 222.72
Mar 222.74
Mar 221.87
Mar 221.77
Mar 221.75
Feb 221.85
Feb 222.13
Feb 222.28
Feb 222.02
Jan 221.99
Jan 221.56
Jan 221.63
Jan 221.72
Dec 211.71
Dec 211.67
Dec 211.8
Dec 211.68
Dec 211.74
Nov 211.94
Nov 211.92
Nov 212.14
Nov 213.62
Oct 213.65
Oct 213.47
Oct 213.38
Oct 213.42
Oct 213.44
Sep 213.74
Sep 213.69
Sep 214.12
Sep 213.95
Aug 214.19
Aug 213.76
Aug 214.02
Aug 213.12
Jul 213.28
Jul 213.41
Jul 213.23
Jul 213.7
Jul 213.71
Jun 215
Jun 214.81
Jun 215.08
Jun 215.3
May 215.46
May 215.1
May 214.98
May 2194.36
Apr 21105.43
Apr 21100.4
Apr 2196.05
Apr 2198.57
Apr 2192.53
Mar 2194.91
Panbela Therapeutics, Inc.
PBLA
Stockpicker

Video analysis: PBLA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.